Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications
The peroxisome proliferator-activated receptors (PPAR-α, PPAR-β/δ, and PPAR-γ) are
members of the nuclear receptor super-family, acting as ligand-inducible transcription …
members of the nuclear receptor super-family, acting as ligand-inducible transcription …
Angiotensin II AT1 receptor blockers as treatments for inflammatory brain disorders
JM Saavedra - Clinical science, 2012 - portlandpress.com
The effects of brain AngII (angiotensin II) depend on AT1 receptor (AngII type 1 receptor)
stimulation and include regulation of cerebrovascular flow, autonomic and hormonal …
stimulation and include regulation of cerebrovascular flow, autonomic and hormonal …
Electrochemical Cyclization of o-Aminyl Azobenzenes: Roles of Aldehydes in N–N Bond Cleavage
A Li, A Gao, K Chen, H Li - Organic Letters, 2024 - ACS Publications
Direct functionalization of azobenzenes provides an approach to obtaining valuable
molecules in synthetic chemistry. However, an efficient method for the cleavage of the N═ N …
molecules in synthetic chemistry. However, an efficient method for the cleavage of the N═ N …
Cross-Dehydrogenative Coupling of Azoles with α-C(sp3)–H of Ethers and Thioethers under Metal-Free Conditions: Functionalization of H–N Azoles via C–H …
A metal-free cross-dehydrogenative coupling method for the synthesis of N-substituted
azoles has been developed. The TBAI/TBHP system catalyzed the coupling of azoles with …
azoles has been developed. The TBAI/TBHP system catalyzed the coupling of azoles with …
Diversity oriented synthesis of benzimidazole-based biheterocyclic molecules by combinatorial approach: a critical review
Heterocyclic compounds play a major role in drug discovery processes as these are the
common structural motif for 80% of the marketed drugs by US retail sales in 2014 …
common structural motif for 80% of the marketed drugs by US retail sales in 2014 …
Discovery of a Series of Imidazo[4,5-b]pyridines with Dual Activity at Angiotensin II Type 1 Receptor and Peroxisome Proliferator-Activated Receptor-γ
A Casimiro-Garcia, GF Filzen, D Flynn… - Journal of medicinal …, 2011 - ACS Publications
Mining of an in-house collection of angiotensin II type 1 receptor antagonists to identify
compounds with activity at the peroxisome proliferator-activated receptor-γ (PPARγ) …
compounds with activity at the peroxisome proliferator-activated receptor-γ (PPARγ) …
Synthesis, antioxidant, and antimicrobial evaluation of some 2-arylbenzimidazole derivatives
B Zhou, B Li, W Yi, X Bu, L Ma - Bioorganic & medicinal chemistry letters, 2013 - Elsevier
A series of 2-arylbenzimidazole derivatives (3a–3p and 4a–4i) were synthesized and
evaluated as potential antioxidant and antimicrobial agents. Their antioxidant properties …
evaluated as potential antioxidant and antimicrobial agents. Their antioxidant properties …
Microwave assisted synthesis and cytotoxic activity evaluations of new benzimidazole derivatives
Abstract Twelve new 2-quinolizinylbenzimidazole and 2-naphthalylbenzimidazole
derivatives with various 5-and 6-positioned substituents (aza, H, CH 3, Cl, NO 2, NH 2, OCH …
derivatives with various 5-and 6-positioned substituents (aza, H, CH 3, Cl, NO 2, NH 2, OCH …
Substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonist: a review
V K. Vyas, M Ghate - Mini reviews in medicinal chemistry, 2010 - benthamdirect.com
The renin angiotensin system (RAS) plays an important role in regulation of blood pressure
and fluidelectrolyte homeostasis. The renin-angiotensin system consists of a cascade of …
and fluidelectrolyte homeostasis. The renin-angiotensin system consists of a cascade of …
Benzimidazoles: an ideal privileged drug scaffold for the design of multitargeted anti-inflammatory ligands
The recent research area endeavors to discover ultimate multi-target ligands, an
increasingly feasible and attractive alternative to existing mono-targeted drugs for treatment …
increasingly feasible and attractive alternative to existing mono-targeted drugs for treatment …